Concepedia

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

José A. Stoute, Joash Gombe, Mark R. Withers, Joram Siangla, Denise McKinney, Melanie Onyango, James F. Cummings, Jessica Milman, Kathryn Tucker, Lorraine Soisson,

Vaccine · 2005 · 100 citations · 19 references

DOI

Concepts

References

19

Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l

Andrea Egan, J Morris, G. Barnish et al. · The Journal of Infectious Diseases · 1996 · 311 citations

, , +17

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1

Michael J. Blackman, Anthony A. Holder · Molecular and Biochemical Parasitology · 1992 · 197 citations

, , +17

Age-Dependent Acquired Protection against Plasmodium Falciparum in People Having Two Years Exposure to Hyperendemic Malaria

J. Kevin Baird, Trevor R. Jones, Emon W. Danudirgo et al. · American Journal of Tropical Medicine and Hygiene · 1991 · 190 citations

, , +9

Human antibodies to the 19 kDa C‐terminal fragment of <i>Plasmodium falciparum</i> merozoite surface protein 1 inhibit parasite growth <i>in vitro</i>

Andrea Egan, Petra A. Burghaus, Pierre Druilhe et al. · Parasite Immunology · 1999 · 156 citations · Full text

, , +17

Efficacy of Two Alternate Vaccines Based on<i>Plasmodium falciparum</i>Merozoite Surface Protein 1 in an<i>Aotus</i>Challenge Trial

Anthony W. Stowers, Vittoria Cioce, Richard L. Shimp et al. · Infection and Immunity · 2001 · 125 citations

, , +17